Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
New words:
accommodate, allergy, andBextra, andEmployment, andEquity, andNorvascfor, antipsychotic, approvedSpiriva, approvedZyvoxfor, asthma, attack, atypical, autoimmune, Avon, bacteria, beta, biopharmaceutical, blocker, breast, broadest, broadly, Burger, Caduet, colorectal, committed, CommitteeandAudit, Compaq, conform, conjuction, copromoteRebifwith, coveringDiflucan, CSL, Deloitte, density, diabetic, DirectorsandNamed, elevated, EllenceandAromasinare, esophageal, Esperion, Expertsin, foot, forCaduetin, forDiflucanexpired, foregoing, GAAP, Geodon, glaucoma, hair, HandiHaler, headingsThe, Henrietta, increasingly, infection, Informationin, inhaled, Inspra, involuntary, ISSUER, Jackson, Kalamazoo, King, LaMattina, lantanoprost, Latin, lipoprotein, Madison, mandating, Melbourne, metabolic, middle, Modernization, molecular, Nordisk, Novo, ocular, ofListerinemouthwash, ofXalatanwith, ophthalmic, ophthalmology, orthopedic, overactive, parasiticide, PMDD, Portage, Productson, prohibition, PTSD, quinapril, recombinant, reproductive, Richland, Roebuck, SAD, sector, sellGenotropinin, sellZyrtecunder, shortly, soft, Spain, spring, St, SudafedandZantac, surgical, swallow, theZithromax, timolol, tissue, toAccuprilexpired, tobacco, toDiflucanexpired, Touche, Township, trademarkZeldox, underGovernment, veterinary, XalatanandDetrol, XR, Yvonne, ZyrtecandDiflucan
Removed:
added, adult, appeal, approvable, arose, asserted, banking, base, brought, build, called, cargo, centralized, Chairman, choose, circulatory, combined, create, debate, decide, decision, diflucan, diluted, discontinued, dismissed, district, Dublin, earned, employee, Euromarket, evaluated, exceeding, expanding, expire, fact, floating, formula, grew, harry, Haute, implement, implicitly, Indiana, initiated, inland, intergovernmental, invalid, investigation, issuance, judgment, kamen, Kodiak, lender, letter, marine, nature, offsetting, opinion, oppose, opt, outstanding, passed, pay, PIBE, plaintiff, prepared, profit, profitable, proposed, purported, received, reorganization, responsible, security, separate, settlement, shift, show, single, source, substantially, suit, Technological, Terre, topical, transaction, transport, trend, University, upheld, voluntarily, XL, zyrtec
Filing tables
Filing exhibits
- 10-K Annual report
- 12 Computation of Ratio of Earnings to Fixed Charges
- 13 Portions of the 2003 Financial Report
- 21 Subsidiaries of the Company
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 23.3 Consent of Deloitte & Touche LLP
- 31.1 Section 302 Certification of the CEO
- 31.2 Section 302 Certification of the CFO
- 32.1 Section 906 Certification of the CEO
- 32.2 Section 906 Certification of the CFO
PFE similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 33-49629, 333-48382, 333-100853, and 33-56435), Form S-4 (Nos. 33-57709 and 333-90975) and Form S-8 (Nos. 2-87473, 33-34139, 33-38708, 33-44053, 33-56979, 33-49631, 33-53713, 33-55771, 33-02061, 333-36371, 333-50899, 333-76839, 333-39606, 333-39610, 333-59660, 333-59654, 333-90975, 333-110571 and 333-111333) of Pfizer Inc. of our report dated March 3, 2003 relating to the financial statements of Pharmacia Corporation which appears in Pharmacia Corporation’s annual report on Form 10-K for the year ended December 31, 2002.
PricewaterhouseCoopers LLP
Florham Park, New Jersey
March 10, 2004